Table 2.
Subjects with normal DST | n | Subjects with abnormal DST | n | |
---|---|---|---|---|
Abnormalities among 326 subjects with data from at least 3 tests | UFC | 6 | DST | 20 |
Sal F RIA | 18 | DST + UFC | 3 | |
Sal F LC-MS/MS | 11 | DST + Sal F RIA | 5 | |
UFC + Sal F RIA | 1 | DST + Sal F LC-MS/MS | 0 | |
UFC + Sal F LC-MS/MS | 1 | DST + Sal F RIA & LC-MS/MS | 1 | |
Sal F RIA and LC-MS/MS | 6 | DST + UFC + Sal F RIA | 1 | |
DST + UFC + Sal F LC-MS/MS | 0 | |||
DST + UFC + Sal F RIA & LC-MS/MS | 1 | |||
Total | 43 | 31 | ||
Abnormalities among 43 subjects with data from only 2 screening tests | ||||
Sal F RIA | 3 | DST | 3 | |
Sal F LC-MS/MS | 2 | |||
UFC + Sal F RIA | 2 | |||
Total | 7 | 3 | ||
Total no. of abnormalities in both groups: 84 |